Nuvision Biotherapies Limited
Manufacture of pharmaceutical preparations · Nottingham
ActiveUnited KingdomIncorporated 2015Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-06-30
IXBRL · 168 source facts · 28 selected values
Validation findingsXBRL valid
Accounts to 2025-06-30
IXBRL · 168 source facts · 28 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-07-01 to 2025-06-30
- Extraction status
- complete
- Numeric facts
- 123
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- IFRS-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2603_09526225_20250630
- Source archive
- Accounts_Monthly_Data-March2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-06-30
IXBRL · 173 source facts · 26 selected values
Validation findingsXBRL valid
Accounts to 2024-06-30
IXBRL · 173 source facts · 26 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-04-01 to 2024-06-30
- Extraction status
- complete
- Numeric facts
- 114
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3600_09526225_20240630
- Source archive
- Accounts_Monthly_Data-February2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-03-31
IXBRL · 163 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2023-03-31
IXBRL · 163 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2022-04-01 to 2023-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 103
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0013_09526225_20230331
- Source archive
- Accounts_Monthly_Data-May2023.zip
Accounts to 2022-03-31
IXBRL · 167 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2022-03-31
IXBRL · 167 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2021-04-01 to 2022-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 107
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0105_09526225_20220331
- Source archive
- Accounts_Monthly_Data-April2022.zip
Accounts to 2021-03-31
IXBRL · 196 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2021-03-31
IXBRL · 196 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2020-04-01 to 2021-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 126
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0092_09526225_20210331
- Source archive
- Accounts_Monthly_Data-July2021.zip
Accounts to 2020-03-31
IXBRL · 188 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2020-03-31
IXBRL · 188 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2019-04-01 to 2020-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 118
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0079_09526225_20200331
- Source archive
- Accounts_Monthly_Data-June2020.zip
Accounts to 2019-03-31
IXBRL · 148 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2019-03-31
IXBRL · 148 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2018-04-01 to 2019-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 81
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0067_09526225_20190331
- Source archive
- Accounts_Monthly_Data-June2019.zip
Accounts to 2018-03-31
IXBRL · 149 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2018-03-31
IXBRL · 149 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2017-04-01 to 2018-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 80
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0056_09526225_20180331
- Source archive
- Accounts_Monthly_Data-July2018.zip
Accounts to 2017-03-31
IXBRL · 126 source facts · 12 selected values
Not assessedlegacy record
Accounts to 2017-03-31
IXBRL · 126 source facts · 12 selected values
Not assessed
legacy record
- Reporting period
- 2016-04-01 to 2017-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 64
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0044_09526225_20170331
- Source archive
- Accounts_Monthly_Data-July2017.zip
Accounts to 2016-03-31
IXBRL · 49 source facts · 8 selected values
Not assessedlegacy record
Accounts to 2016-03-31
IXBRL · 49 source facts · 8 selected values
Not assessed
legacy record
- Reporting period
- 2015-04-07 to 2016-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 15
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0031_09526225_20160331
- Source archive
- Accounts_Monthly_Data-June2016.zip
Registered details
09526225- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2015-04-07
- Jurisdiction
- —
- Registered office
- MEDICITY, D6 BUILDING, THANE ROAD, NOTTINGHAM, NG90 6BH, ENGLAND
Classification
1 SIC codes21200
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
4 matched grantsTereo processed amniotic membrane (TPAM); A novel mainstream global therapy for moderate-to-severe dry eye diseaseLead
Innovate UK · Collaborative R&D · 2023-03-01 – 2024-11-30
£699,827
awarded
COVID-19: Optimised production system for Omnigen: An innovative regenerative therapy for in-clinic management of wound careLead
Innovate UK · Feasibility Studies · 2020-06-01 – 2021-02-28
£138,000
awarded
Optimised production system for Omnigen: An innovative regenerative therapy for in-clinic management of wound careLeadInnovate UK · Collaborative R&D · 2018-03-01 – 2020-12-31 · with 1 other participant£601,937awarded
Optimised production system for Omnigen: An innovative regenerative therapy for in-clinic management of wound careLead
Innovate UK · Collaborative R&D · 2018-03-01 – 2020-12-31 · with 1 other participant
£601,937
awarded
Nuvision Biotherapies Limitedlead£601,937
University of Nottingham£283,438
Omnigen: Novel Stem Cell Treatment for Acute Ocular Surface TraumaLead
Innovate UK · Feasibility Studies · 2015-11-01 – 2017-03-31
£105,721
awarded
Scaleup signal
OECD growth threshold met
21% employee CAGR
University stake evidence
The University Of Nottingham
psc · 25-50% band